Literature DB >> 5953406

Contrast media. Myeloma protein precipitates in urography.

E C Lasser, J H Lang, Z A Zawadzki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5953406     DOI: 10.1001/jama.198.8.945

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Questionnaires for examinations using iodinated contrast media and their grades of recommendation: Japan Radiological Society/Japanese College of Radiology Joint Committee on Contrast Media Safety.

Authors:  Hiromitsu Hayashi; Yoshifumi Narumi; Ryo Takagi; Yasuo Takehara; Yasuaki Arai; Ryohei Kuwatsuru; Yukunori Korogi; Hideharu Sugimoto; Yoshito Tsushima; Katsumi Hayakawa; Kunihiko Fukuda; Shozo Tamura; Sachio Kuribayashi
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

2.  Renal failure after radiological contrast media.

Authors:  J McEvoy; M G McGeown; R Kumar
Journal:  Br Med J       Date:  1970-12-19

3.  Contrast media and the kidney.

Authors: 
Journal:  Br Med J       Date:  1971-04-03

4.  Acute reactions to urographic contrast media.

Authors:  P Davies; M B Roberts; J Roylance
Journal:  Br Med J       Date:  1975-05-24

5.  Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.

Authors:  Maeve P Crowley; Vinitha N Prabhakaran; Oonagh M Gilligan
Journal:  Pathol Oncol Res       Date:  2017-09-13       Impact factor: 3.201

6.  Urography in myelomatosis.

Authors:  M T Cwynarski; H M Saxton
Journal:  Br Med J       Date:  1969-02-22

Review 7.  Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Michele Bertolotto; Henrik S Thomsen; Gabriele Pozzato; Donatella Ugolini; Marie-France Bellin; Georg Bongartz; Olivier Clement; Gertraud Heinz-Peer; Aart van der Molen; Peter Reimer; Judith A W Webb
Journal:  Eur Radiol       Date:  2017-08-30       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.